API
BIIB icon

Advisor Partners II’s Biogen BIIB Stock Holding History

Advisor Partners II’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.48M Buy
5,750
+148
+3% +$39.6K 0.06% 357
2023
Q2 		$1.6M Buy
5,602
+1,624
+41% +$483K 0.07% 272
2023
Q1 		$1.11M Buy
3,978
+526
+15% +$146K 0.06% 327
2022
Q4 		$956K Buy
3,452
+761
+28% +$215K 0.06% 332
2022
Q3 		$718K Buy
+2,691
New +$572K 0.05% 353

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Partners II's BIIB Position: Q3 2023 in Review

Advisor Partners II increased its Biogen (BIIB) stake by 2.6% in Q3 2023, buying an estimated $39.6K and bringing the position to 5,750 shares worth $1.48M. The position accounts for 0.06% of the portfolio, ranked #357.

Advisor Partners II first reported a position in BIIB in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.6M in Q2 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Advisor Partners II held 5,750 shares of Biogen worth $1.48M as of Q3 2023.
  • Advisor Partners II bought 148 Biogen shares in Q3 2023, an estimated $39.6K.
  • Biogen made up 0.06% of Advisor Partners II's portfolio in Q3 2023, its #357 holding.
  • Advisor Partners II first reported a position in Biogen in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Biogen position peaked at $1.6M in Q2 2023.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.